logo

Indian News

Share

pharma-031918_22feb19.jpg Shares of Achieve Life Sciences Inc. (ACHV) are up over 30% in pre-market trading on Friday, following encouraging final data from its phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of Cytisinicline in smokers.

asian-mixed2_22feb19.jpg Asian stocks ended mixed on Friday as hopes for Chinese stimulus helped offset weak economic readings from the U.S. and Europe. Investors continued to keep a close eye on high-level talks between U.S. and Chinese trade negotiators in Washington, as the two sides face a March 1 deadline to avoid a...

pharma-022618_21feb19.jpg Today's Daily Dose brings you news about Exact Sciences' better-than-expected Q4 financial results; Merck's acquisition of Immune Design; Nevro's lackluster revenue outlook; Opiant Pharma' s disappointing Bulimia Nervosa study results; and near-term catalyst of Zosano Pharma.

pharma-010517_21feb19.jpg The FDA has added Boxed Warning to the label of gout medicine Uloric that highlights the increased risk of death with the drug.

fake-feb21.jpg The World Health Organization has warned consumers to be on vigil against fake versions of leukemia drug Iclusig sold in Europe and the Americas.

pharma-031518_21feb19.jpg Today's Daily Dose brings you news about Achieve Life Sciences' progress in ORCA-1 trial; Agios Pharma's near-term regulatory catalyst; new development related to ARCA biopharma's PRECISION-AF pivotal study; financial outlook of Genomic Health and NuVasive; near-term clinical trial catalyst of Sarepta; and partial clinical hold on Xencor's phase I acute myeloid leukemia trial.

pharma-030117_20feb19.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharma-032917_20feb19.jpg Eton Pharmaceuticals Inc. (ETON), which made its public debut last November, touched a new high of $7.49 yesterday.

pharma-032317_20feb19.jpg Today's Daily Dose brings you news about Bausch Health's acquisition of the U.S. rights to Eton Pharma's EM-100 eye drop; Cellular Biomedicine's business highlights and financial results for Q4, 2018; CE Mark approval for Edwards Lifesciences' PASCAL transcatheter valve repair system; Invitae's better-than-expected Q4 financial results among others.

pharmaup-feb19.jpg The following are some of today's top gainers in the pharma/biotech sector.

Follow RTT